Most of the directive thrust in Cancer Research comes from the efforts put in by the National Cancer Institute (NCI) of U.S.A. At present it is estimated that in the United States of America, one person in three will contract cancer, and one person in five will die of Cancer. Since 1954
the U.S. Federal Government, originally through the Cancer Chemotherapy
National Service Center and subsequently through the National Cancer lnstitute
(NCI), is being deeply involved in the discovery, biological evaluation,
and clinica' testing of anti cancer agents from both synthetic and natural
sources. Hartwel , in a series of articles in lioydia has reviewed these early Records. National
Cancer Institute throug~ programme surveyed some 35,000 plants and tested
for their cvto-toxic activity, typically in the human carcinoma of the
nasopharings and mouse lymphyocytic leukemia test systems . in spite of
the fact that a number of key compounds came out of this programme none
of these have yet impacted the market place , at present some of the plant
derived natural products are becoming or attracting the attention of oncologists
. they are the bisindole alkaloids drived from catharanthus , vinblastine
, vincristine and a semi synthetic derivative Vinblastine, Vindisine and
other plant derivatives. Currently Vindisine, Homo-herringtonine, Ipomeanol,
Pancratistatin, Phyllanthoside and taxol, etc. The present series of articles
in this journal try to highlight some of the natural I?roducts from pl<;Jnt
sources that are considered at least as synergisers to the available chemotherapeutic
agents in the management of Cancer. This article initiates a continuous process of presenting plants having antitumor effects. To start with ASWAGANDHA WITHANIA SOMNIFERA L., (DUN.) is being presented here, highlighting some of its antitumor effects. |
|||||||||||||||
Back to Top | |||||||||||||||
Copyright
© 2003 A M Charitable Trust., All rights reserved
|